glp 1 in the brain Frontiers GLP-1 and the Degenerating Brain:

GIP + GLP-1 refers to a new generation of weight-loss medications that combine two powerful gut-derived hormones: Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1)

Chan, P., Shao, L., Tomlinson, B., Zhang, Y

Achieving sustainable weight loss and health improvements requires accountability and dedication over time

Peptide protocols for aging adults address additional strategies for men and women navigating the metabolic changes of midlife

When GLP-1 receptor agonists like semaglutide or tirzepatide bind to these receptors, one of their effects is slowing the rate at which food moves from the stomach to the small intestine

Foundayo was FDA-approved in April 2026 and is available at Endocare in Dubai and Abu Dhabi